市場調查報告書
商品編碼
1451879
2024-2032 年按技術(生命科學試劑、分析試劑)、應用(蛋白質合成和純化、基因表現、DNA 和 RNA 分析、藥物測試等)和地區分類的生物技術試劑市場報告Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032 |
2023年,全球生物技術試劑市場規模達到854.101億美元。展望未來, IMARC Group預計到2032年市場規模將達到1,658.195億美元,2024-2032年複合年成長率(CAGR)為7.42%。生命科學領域研發(R&D)活動的增加、對個人化醫療和標靶治療的需求不斷成長、基因組學和蛋白質組學研究的快速進步以及慢性病和傳染病患者病率的激增是推動這一趨勢的一些關鍵因素。市場。
生物技術試劑在生命科學領域發揮關鍵作用,促進了各種研究和診斷應用。它們是生物技術過程中使用的重要組成部分,可實現生物分子和系統的分離、分析和操作。它們透過細緻的製造程序製成,旨在提供準確可靠的結果,確保實驗和研究的進展和成功。生物技術試劑的主要優勢之一是其在生命科學多個學科中的多功能性和廣泛適用性。它們被用於各種研究領域,如基因組學、蛋白質組學、細胞生物學、分子診斷和藥物發現,因為它們使科學家能夠提取和純化脫氧核糖核酸(DNA)、核糖核酸(RNA) 和蛋白質,以及進行分析、檢測生物標記並進行基因表現研究。生物技術試劑也促進新治療藥物、疫苗和個人化藥物的開發,促進醫療保健和疾病治療的進步。
全球生物技術試劑市場受到多種因素的推動,包括生命科學領域不斷增加的研發 (R&D) 活動以及對個人化醫療和標靶治療的需求不斷成長。此外,基因組學和蛋白質組學研究的快速進步以及慢性病和傳染病患者病率的激增正在加速市場的成長。除此之外,生物技術和分子生物學的技術進步以及製藥和生物技術行業的擴張正在為市場成長提供動力。此外,對醫療基礎設施和政府舉措的投資以及對研究項目的資助的迅速成長也是推動成長的因素。與此一致的是,學術機構和行業參與者之間不斷升級的合作以及對分子診斷的認知和採用的不斷提高正在支持市場的成長。此外,生物資訊學和計算生物學的出現以及生物樣本庫和生物樣本庫設施的擴展正在促進市場成長。其他因素,例如對獲得準確實驗結果的高品質試劑的需求激增、農業中對基因改造生物(GMO)的需求不斷增加,以及針對新興應用(例如CRISPR/Cas9 基因編輯)開發新型試劑,都是正面的因素。為市場成長做出貢獻。
The global biotechnology reagents market size reached US$ 85,410.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 165,819.5 Million by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.
Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.
The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Life Science Reagents
PCR
Cell Culture
Hematology
In-Vitro Diagnostics
Others
Analytical Reagents
Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Others
A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).
Protein Synthesis and Purification
Gene Expression
DNA and RNA Analysis
Drug Testing
Others
A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.
The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.